A citation-based method for searching scientific literature

Juan Undurraga, Ross J Baldessarini. Neuropsychopharmacology 2012
Times Cited: 139







List of co-cited articles
765 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A rating scale for depression.
M HAMILTON. J Neurol Neurosurg Psychiatry 1960
19

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.
Irving Kirsch, Brett J Deacon, Tania B Huedo-Medina, Alan Scoboria, Thomas J Moore, Blair T Johnson. PLoS Med 2008
19

Antidepressant drug effects and depression severity: a patient-level meta-analysis.
Jay C Fournier, Robert J DeRubeis, Steven D Hollon, Sona Dimidjian, Jay D Amsterdam, Richard C Shelton, Jan Fawcett. JAMA 2010
17

A new depression scale designed to be sensitive to change.
S A Montgomery, M Asberg. Br J Psychiatry 1979
16

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Andrea Cipriani, Toshi A Furukawa, Georgia Salanti, Anna Chaimani, Lauren Z Atkinson, Yusuke Ogawa, Stefan Leucht, Henricus G Ruhe, Erick H Turner, Julian P T Higgins,[...]. Lancet 2018
769
14

Selective publication of antidepressant trials and its influence on apparent efficacy.
Erick H Turner, Annette M Matthews, Eftihia Linardatos, Robert A Tell, Robert Rosenthal. N Engl J Med 2008
12

Placebo response in studies of major depression: variable, substantial, and growing.
B Timothy Walsh, Stuart N Seidman, Robyn Sysko, Madelyn Gould. JAMA 2002
801
12

Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies.
Toshi A Furukawa, Andrea Cipriani, Lauren Z Atkinson, Stefan Leucht, Yusuke Ogawa, Nozomi Takeshima, Yu Hayasaka, Anna Chaimani, Georgia Salanti. Lancet Psychiatry 2016
94
12

Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database.
Arif Khan, Robyn M Leventhal, Shirin R Khan, Walter A Brown. J Clin Psychopharmacol 2002
313
10


Antidepressants versus placebo for depression in primary care.
Bruce Arroll, C Raina Elley, Tana Fishman, Felicity A Goodyear-Smith, Tim Kenealy, Grant Blashki, Ngaire Kerse, Stephen Macgillivray. Cochrane Database Syst Rev 2009
189
10



Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
Madhukar H Trivedi, A John Rush, Stephen R Wisniewski, Andrew A Nierenberg, Diane Warden, Louise Ritz, Grayson Norquist, Robert H Howland, Barry Lebowitz, Patrick J McGrath,[...]. Am J Psychiatry 2006
9

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz,[...]. Am J Psychiatry 2006
9

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.
Andrea Cipriani, Toshiaki A Furukawa, Georgia Salanti, John R Geddes, Julian Pt Higgins, Rachel Churchill, Norio Watanabe, Atsuo Nakagawa, Ichiro M Omori, Hugh McGuire,[...]. Lancet 2009
8

Antidepressant effects of ketamine in depressed patients.
R M Berman, A Cappiello, A Anand, D A Oren, G R Heninger, D S Charney, J H Krystal. Biol Psychiatry 2000
8

Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report.
Stephen R Wisniewski, A John Rush, Andrew A Nierenberg, Bradley N Gaynes, Diane Warden, James F Luther, Patrick J McGrath, Philip W Lavori, Michael E Thase, Maurizio Fava,[...]. Am J Psychiatry 2009
161
8

Meta-analysis of the placebo response in antidepressant trials.
Winfried Rief, Yvonne Nestoriuc, Sarah Weiss, Eva Welzel, Arthur J Barsky, Stefan G Hofmann. J Affect Disord 2009
157
8

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, Nancy E Brutsche, Rezvan Ameli, David A Luckenbaugh, Dennis S Charney, Husseini K Manji. Arch Gen Psychiatry 2006
7

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
Nanxin Li, Boyoung Lee, Rong-Jian Liu, Mounira Banasr, Jason M Dwyer, Masaaki Iwata, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Science 2010
7

A model of placebo response in antidepressant clinical trials.
Bret R Rutherford, Steven P Roose. Am J Psychiatry 2013
151
7

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).
Ronald C Kessler, Patricia Berglund, Olga Demler, Robert Jin, Doreen Koretz, Kathleen R Merikangas, A John Rush, Ellen E Walters, Philip S Wang. JAMA 2003
6

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.
James W Murrough, Dan V Iosifescu, Lee C Chang, Rayan K Al Jurdi, Charles E Green, Andrew M Perez, Syed Iqbal, Sarah Pillemer, Alexandra Foulkes, Asim Shah,[...]. Am J Psychiatry 2013
592
6

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.
James W Murrough, Andrew M Perez, Sarah Pillemer, Jessica Stern, Michael K Parides, Marije aan het Rot, Katherine A Collins, Sanjay J Mathew, Dennis S Charney, Dan V Iosifescu. Biol Psychiatry 2013
404
6

Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy.
Raymond W Lam, Sidney H Kennedy, Sophie Grigoriadis, Roger S McIntyre, Roumen Milev, Rajamannar Ramasubbu, Sagar V Parikh, Scott B Patten, Arun V Ravindran. J Affect Disord 2009
293
6


Declining efficacy in controlled trials of antidepressants: effects of placebo dropout.
Stein Schalkwijk, Juan Undurraga, Leonardo Tondo, Ross J Baldessarini. Int J Neuropsychopharmacol 2014
19
31

A randomized controlled trial of intranasal ketamine in major depressive disorder.
Kyle A B Lapidus, Cara F Levitch, Andrew M Perez, Jess W Brallier, Michael K Parides, Laili Soleimani, Adriana Feder, Dan V Iosifescu, Dennis S Charney, James W Murrough. Biol Psychiatry 2014
226
5

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.
Nancy Diazgranados, Lobna Ibrahim, Nancy E Brutsche, Andrew Newberg, Phillip Kronstein, Sami Khalife, William A Kammerer, Zenaide Quezado, David A Luckenbaugh, Giacomo Salvadore,[...]. Arch Gen Psychiatry 2010
596
5

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.
Anita E Autry, Megumi Adachi, Elena Nosyreva, Elisa S Na, Maarten F Los, Peng-fei Cheng, Ege T Kavalali, Lisa M Monteggia. Nature 2011
5

The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.
Isabella Pacchiarotti, David J Bond, Ross J Baldessarini, Willem A Nolen, Heinz Grunze, Rasmus W Licht, Robert M Post, Michael Berk, Guy M Goodwin, Gary S Sachs,[...]. Am J Psychiatry 2013
358
5

Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010.
Alize J Ferrari, Fiona J Charlson, Rosana E Norman, Scott B Patten, Greg Freedman, Christopher J L Murray, Theo Vos, Harvey A Whiteford. PLoS Med 2013
5


The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice.
R van der Lem, N J A van der Wee, T van Veen, F G Zitman. Psychol Med 2011
43
11

Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial.
Maju Mathews, Carl Gommoll, Dalei Chen, Rene Nunez, Arif Khan. Int Clin Psychopharmacol 2015
46
10


The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults.
Kelly Posner, Gregory K Brown, Barbara Stanley, David A Brent, Kseniya V Yershova, Maria A Oquendo, Glenn W Currier, Glenn A Melvin, Laurence Greenhill, Sa Shen,[...]. Am J Psychiatry 2011
5

Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data.
Konstantinos N Fountoulakis, Hans-Jürgen Möller. Int J Neuropsychopharmacol 2011
77
6

The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial.
Andre R Brunoni, Leandro Valiengo, Alessandra Baccaro, Tamires A Zanão, Janaina F de Oliveira, Alessandra Goulart, Paulo S Boggio, Paulo A Lotufo, Isabela M Benseñor, Felipe Fregni. JAMA Psychiatry 2013
305
5



Active placebos versus antidepressants for depression.
J Moncrieff, S Wessely, R Hardy. Cochrane Database Syst Rev 2004
147
4

Grand challenges in global mental health.
Pamela Y Collins, Vikram Patel, Sarah S Joestl, Dana March, Thomas R Insel, Abdallah S Daar, Warwick Anderson, Muhammad A Dhansay, Anthony Phillips, Susan Shurin,[...]. Nature 2011
988
4

Ketamine administration in depressive disorders: a systematic review and meta-analysis.
Guillaume Fond, Anderson Loundou, Corentin Rabu, Alexandra Macgregor, Christophe Lançon, Marie Brittner, Jean-Arthur Micoulaud-Franchi, Raphaelle Richieri, Philippe Courtet, Mocrane Abbar,[...]. Psychopharmacology (Berl) 2014
165
4


Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.
James W Murrough, Katherine E Burdick, Cara F Levitch, Andrew M Perez, Jess W Brallier, Lee C Chang, Alexandra Foulkes, Dennis S Charney, Sanjay J Mathew, Dan V Iosifescu. Neuropsychopharmacology 2015
68
5

Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.
Nanxin Li, Rong-Jian Liu, Jason M Dwyer, Mounira Banasr, Boyoung Lee, Hyeon Son, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Biol Psychiatry 2011
653
4

Synaptic dysfunction in depression: potential therapeutic targets.
Ronald S Duman, George K Aghajanian. Science 2012
669
4

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.
Marije aan het Rot, Katherine A Collins, James W Murrough, Andrew M Perez, David L Reich, Dennis S Charney, Sanjay J Mathew. Biol Psychiatry 2010
406
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.